ABSTRACT
OBJECTIVE: This study was to evaluate the prevalence rate of group B streptococcal infection in pregnant women after 35th gestational week and the relationship between group B streptococcal infection and the prognosis of pregnant women and their neonates. METHODS: From January 1, 2000 to June 30, 2001, the medical records of 204 pregnant women who had visited department of Ob and Gyn, Inha Hospital for antenatal care were reviewed. The specimen were obtained from lower vaginal wall and perineum, and were inoculated on selective media to isolate group B streptococci. The relationship between group B streptococcal infection in those pregnant women and the prognosis of them and their neonates peripartum were evaluated. RESULTS: The prevalence of group B streptococci in pregnant women was 1.96% (4/204). No group B streptococcal infection was found in their neonates (0/4). There is no significant statistical differences in prognosis between the pregnant women with group B streptococci and those without group B streptococi. CONCLUSION: This study was revealed that the prevalence rate of group B streptococci in pregnant women was very low and the screening test for group B streptococcal infection in pregnant women might be regarded as meaningless. However, group B streptococcus has been known to cause many complications in pregnant women and their neonates. Further studies are needed for the significance of group B streptococcal infection in pregnant women and their neonates.
Subject(s)
Female , Humans , Infant, Newborn , Mass Screening , Medical Records , Perineum , Peripartum Period , Pregnant Women , Prevalence , Prognosis , Streptococcal Infections , StreptococcusABSTRACT
Carcinomas of the lung, breast and lymphoma account for approximately 75% of malignant pleural effusions and the metastatic ovarian carcinoma is the fourth leading cause of malignant pleural effusions. The diagnosis of a malignant pleural effusion is established by demonstrating malignant cells in the pleural fluid or in the pleural biopsy. Chemical pleurodesis should be considered in cases of patients with malignant pleural effusion, who were not responded with systemic chemotherapy. We experienced a case of malignant pleural effusion treated by chemical pleurodesis, which was developed in a patient with ovarian carcinoma and we report it with the brief review or literatures.
Subject(s)
Humans , Biopsy , Breast , Diagnosis , Drug Therapy , Lung , Lymphoma , Pleural Effusion, Malignant , PleurodesisABSTRACT
Tuberculosis of the uterine cervix is a rare disorder and the cervix is reported to be involved in 5-15 percent of the case of genital tuberculosis. It is discovered incidentally in most cases. The genital lesions are secondary to tuberculosis elsewhere, usually, the lungs. Primary cervical tuberculosis is very rare. The cytologic diagnosis of cervical tuberculosis is difficult. The histological diagnosis of genital tuberculosis presents no problems when the typical caseating necrosis and Langhans giant cell granulomas are present in tissue. And the presence of tubercle bacilli in biopsy specimens as well as in cultures of one specimen confirmed the diagnosis. We report a case of tuberculosis of the cervix confirmed by histologic examination with brief review.